Ocumetics Announces Completion of First Tranche of Debenture Private Placement for Net Proceeds of CA$2.82 Million
medical device investing Ocumetics Technology: Pioneering Vision Enhancement with the Ocumetics Accommodating Lens
life science investing Ocumetics Continues to Meet Significant Development Milestones; Lens Design Optimized for Upcoming First in Human Study
life science investing Ocumetics Welcomes Dr. Doyle Stulting and Dr. Bart McRoberts to Board of Directors
